Attention www.globalkeysolutions.net is now www.keypedia.com, read the full press release here.
KeyPedia LogoKeyPedia Icon
  1. Home
  2. /
  3. Records
  4. /
  5. Warning Letter
  6. /
  7. Walmart, Inc
WARNING LETTER
•Walmart, Inc•November 26, 2025

Walmart, Inc – FDA Warning Letter, Nov 26, 2025

Record Details

On December 12, 2025, the U.S. Food and Drug Administration (FDA) issued a Warning Letter to Walmart, Inc., regarding serious violations related to the continued sale of recalled ByHeart Whole Nutrition Infant Formula. Beginning in November 2025, an investigation by FDA and its partners linked this formula to a multistate infant botulism outbreak, affecting 51 infants. The presence of *Clostridium botulinum* renders the product adulterated under section 402(a)(1) of the Federal Food, Drug, and Cosmetic Act (FD&C Act).

Despite receiving written notifications of the voluntary recall and its expansion on November 8 and November 11, 2025, regulatory visits confirmed that the recalled infant formula remained available for purchase on shelves in numerous Walmart stores across 21 states between November 12 and November 26, 2025. This constitutes a violation of section 301(c) of the FD&C Act, concerning the receipt and delivery of adulterated food in interstate commerce. Walmart store associates cited various explanations, including lack of awareness and confusion regarding the recall scope.

The FDA held a discussion with Walmart"s CEO on November 18, 2025, to address the ineffectiveness of the recall within their stores. However, despite multiple follow-up emails, Walmart has not provided information demonstrating implemented corrective actions. The FDA requires Walmart to notify the agency in writing within 15 working days, detailing specific steps taken to address violations, prevent recurrence, and provide supporting documentation. Failure to adequately respond may result in legal actions such as seizure or injunction.

Company
Walmart, Inc
Inspection date
November 26, 2025
Product type
Other
Office
Office of Compliance and Enforcement
People
  • Katherine Arnold
  • Ann M. Oxenham (Director)
View Company Profile

ID · 0863bf88-e04e-4826-b7e9-310d77c7a716

Violation Codes4
FD&C Act 402(a)(1)21 U.S.C. 342(a)(1)FD&C Act 301(c)21 U.S.C. 331(c)

Full citation text and observation details available on the Dashboard.

Other documents for Walmart, Inc
  • WARNING_LETTER - 2024-07-30July 30, 2024
  • WARNING_LETTER - 2023-08-18August 18, 2023

Your cart

Your cart is empty.

Browse public document pages and click Buy this document. We'll ask for your email at checkout, no account needed up front.

Browse documents

Discuss this record with AI

KeyPedia

ChatGPT

Claude

Perplexity

Grok

Copilot

Document or profile

One record shows the event. A profile shows the pattern.

Buy this document for the source file and details behind this single event.

Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.

Explore Walmart, Inc
KeyPedia
Regulatory Data Transformed
Stay in the loop

KRA score changes, company updates and news. About monthly, unsubscribe anytime.

Contact
New York Office:
370 Jay Street 7th Floor
Brooklyn, NY 11201
Scranton Office:
Scranton Enterprise Center, Suite 217
201 Lackawanna Avenue
Scranton, PA, 18503
🇺🇸+1 917-789-5099
🇪🇺+48 532-447-507
info@keypedia.com
Quick Links
HomePlatform OverviewMedia
KeyPedia™ Lite
Browse HubDatabase DirectoryRecordsCompaniesOfficesPeopleCareersAbout UsFounding TeamMeet Our ExpertsPartners
Legal & Ethics
Privacy PolicyTerms of ServiceOur Values & MissionCode of Ethics & AI Policy
©2026 KeyPedia™ | Global Key Solutions Corp. All rights reserved.